Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acacia Pharma
Acacia Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Barhemsys
Amisulpride
2020-02-26
2031-2038
—
Byfavo
Remimazolam
2020-10-06
2027-2033
Conscious sedation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amisulpride
healthy volunteers/patients
,
chronic kidney failure
,
postoperative nausea and vomiting
,
vomiting
,
nausea
Calcium dobesilate
castration-resistant prostatic neoplasms
,
non-hodgkin lymphoma
,
colorectal neoplasms
,
esophageal neoplasms
,
esophageal squamous cell carcinoma
,
multiple myeloma
,
plasma cell neoplasms
,
prostatic neoplasms
,
lung neoplasms
,
male genital neoplasms
,
non-small-cell lung carcinoma
,
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
vomiting
,
nausea
,
neoplasms
,
postoperative nausea and vomiting
,
drug-related side effects and adverse reactions
,
sarcoma
Bos taurus adrenal cortex corticosteroids
healthy volunteers/patients
Anthracycline
vomiting
APD209
wasting syndrome
,
cachexia
Trinessa
anemia
Isoxaflutole
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
carcinoma
,
hearing loss
,
deafness
,
malignant mesothelioma
,
mesothelioma
,
asthma
,
infertility
,
female infertility
,
macular degeneration
,
pituitary acth hypersecretion
,
acth-secreting pituitary adenoma
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
multiple sclerosis
,
fatigue
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
hematologic diseases
,
hematopoietic stem cell transplantation
,
bone marrow transplantation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use